Enabling drug discovery and development through single-cell imaging

Area of Science:

• Biotechnology
• Drug Discovery
• Cellular Analysis

Background:

• Single-cell imaging assays are increasingly vital in drug discovery.
• These assays enable interrogation of rare cell subpopulations with high sensitivity and multiplexing.
• Technological advancements have significantly boosted the throughput and capabilities of these methods.

Purpose of the Study:

• To review key single-cell imaging technologies used in drug discovery.
• To highlight the utility of these methods in understanding cellular heterogeneity and target engagement.
• To discuss the future potential and challenges of single-cell imaging in therapeutic development.

Main Methods:

• Single-cell microscopy combined with microfluidics.
• Mass spectrometric imaging for subcellular compound localization.
• Imaging mass cytometry (IMC) for high-parameter single-cell analysis.

Main Results:

• These technologies offer scalability and multiplexing for detailed cellular analysis.
• They provide definitive data on cellular heterogeneity and target engagement.
• Examples demonstrate their utility in advancing drug discovery pipelines.

Conclusions:

• Single-cell analysis is crucial for developing safer, more effective therapies, especially for novel modalities like CAR-T and gene editing.
• Adoption requires investment in advanced computational and bioinformatic tools to handle complex imaging data.
• These approaches promise to revolutionize personalized medicine and targeted drug development.